AQP4 and dementia: As such, Aqp-4 may prove to be a useful peripheral blood biomarker of MxD or VaD, reflecting vascular and inflammatory changes in the brain as a result of AD pathology with concomitant vascular dysfunction, thereby allowing for stratification of patients with a more complex dementia and guiding potential treatment options.